Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001753926-26-002033·Hexstone Capital LLC
Schedule 13G ownership disclosure
Actuate Therapeutics Inc
Common Stock, par value $0.000001 per share · CUSIP: 005083100
Event date: 2026-10-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hexstone Capital LLC
Shares: 4,225,352.00 · Class: 7.7%
- Brendan O'Neil
Shares: 4,225,352.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-26-002033
- Form type
- SCHEDULE 13G
- Filer
- Hexstone Capital LLC
- CIK
- CIK 2066973
- Filed
- Oct 30, 2026
- Reporting period
- Oct 27, 2026
- Description
- Schedule 13G beneficial ownership